Semi-Annual Consolidated Statement Of Income

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7714007

Concept 2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
12,492,537,000 JPY
10,680,225,000 JPY
88,154,000 JPY
12,232,315,000 JPY
976,794,000 JPY
-260,221,000 JPY
739,050,000 JPY
12,404,382,000 JPY
8,312,000 JPY
11,495,901,000 JPY
1,306,725,000 JPY
33,382,000 JPY
9,522,491,000 JPY
-141,641,000 JPY
693,902,000 JPY
11,637,543,000 JPY
81,042,000 JPY
11,556,501,000 JPY
Cost of sales
7,668,184,000 JPY
8,314,805,000 JPY
Ordinary profit (loss)
1,015,158,000 JPY
-921,042,000 JPY
Gross profit (loss)
4,564,131,000 JPY
3,181,095,000 JPY
Extraordinary income
657,453,000 JPY
483,849,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
4,222,186,000 JPY
4,365,278,000 JPY
Extraordinary losses
266,587,000 JPY
937,463,000 JPY
Profit (loss) before income taxes
1,406,024,000 JPY
-1,374,656,000 JPY
Operating profit (loss)
355,481,000 JPY
731,009,000 JPY
-10,056,000 JPY
341,944,000 JPY
44,989,000 JPY
-13,536,000 JPY
-199,794,000 JPY
365,537,000 JPY
-210,665,000 JPY
-1,184,182,000 JPY
110,436,000 JPY
-159,691,000 JPY
-1,158,048,000 JPY
-13,764,000 JPY
1,138,000 JPY
-1,170,417,000 JPY
35,746,000 JPY
-1,206,164,000 JPY
Income taxes - current
29,935,000 JPY
108,265,000 JPY
Non-operating income
Interest income
13,003,000 JPY
13,436,000 JPY
Dividend income
JPY
0 JPY
Share of profit of entities accounted for using equity method
173,227,000 JPY
513,338,000 JPY
Non-operating income
1,100,830,000 JPY
691,145,000 JPY
Income taxes - deferred
-182,863,000 JPY
436,452,000 JPY
Non-operating expenses
Interest expenses
268,887,000 JPY
284,296,000 JPY
Non-operating expenses
427,615,000 JPY
428,005,000 JPY
Income taxes
-152,927,000 JPY
544,718,000 JPY
Extraordinary income
Gain on sale of non-current assets
4,321,000 JPY
5,150,000 JPY
Profit (loss)
1,558,952,000 JPY
-1,919,375,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
8,364,000 JPY
Impairment losses
1,830,000 JPY
1,250,000 JPY
Profit (loss) attributable to non-controlling interests
-6,480,000 JPY
22,020,000 JPY
Profit (loss) attributable to owners of parent
1,565,433,000 JPY
-1,941,395,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
3,770,779,000 JPY
3,284,705,000 JPY
Foreign currency translation adjustment
-61,935,000 JPY
-398,771,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-2,723,000 JPY
38,993,000 JPY
Other comprehensive income
3,706,120,000 JPY
2,924,926,000 JPY
Comprehensive income
5,265,073,000 JPY
1,005,551,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,271,638,000 JPY
983,087,000 JPY
Comprehensive income attributable to non-controlling interests
-6,565,000 JPY
22,464,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.